Qi Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qi Zhang has a total of 212 co-authors. Here are the top co-authors by number of shared publications:
Wei Wu
State Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing 100193, China
8 shared publications- Zhongzhou Chen
State Key Laboratory of Animal Biotech Breeding, College of Biological Sciences, China Agricultural University, Beijing 100193, China
8 shared publications Lin Yu
State Key Laboratory of Agrobiotechnology, China Agricultural University, Beijing 100193, China
6 shared publications- Yufeng Tong
Department of Chemistry and Biochemistry, University of Windsor, Windsor, Canada
6 shared publications Aiping Dong
Structural Genomics Consortium, University of Toronto, Toronto, Canada
5 shared publications- Chen Davidovich
Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia
5 shared publications
Latest Publications
- Open Access
- 30 October 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44  (23) , 6979-7020
Auto-inhibition of PRC2 by the broadly expressed long isoform of AEBP2
Polycomb Repressive Complex 2 (PRC2) is an essential chromatin regulator responsible for mono-, di- and tri-methylating H3K27. Control of PRC2 activity is a critical process in development and disease, yet no inhibitory cofactor has been identified in somatic cells. Here, we show that the alternative isoforms of its accessory subunit AEBP2, namely AEBP2 S (short) and AEBP2 L (long), perform opposite functions in modulating PRC2 activity. Contrary to prior assumptions that AEBP2 enhances PRC2 function, we find that the widely expressed AEBP2 L isoform inhibits it. AEBP2 L is expressed throughout embryogenesis and adulthood and inhibits PRC2 DNA binding, histone methyltransferase activity, and binding to target genes. In contrast, AEBP2 S , expressed during early embryogenesis, promotes PRC2 DNA-binding activity and is essential for de novo repression of target genes during the transition from naĂ¯ve to primed pluripotency. Mechanistically, through high-resolution cryo-EM and mutagenesis, we show that the recently evolved, negatively charged N-terminal region of AEBP2 L inhibits PRC2. We propose a scenario in which the N-terminus of AEBP2 L arose in vertebrates to restrain PRC2 activity in somatic cells.
- 30 October 2025
- Published by Springer Nature in The EMBO Journal
- Vol. 44  (23) , 6979-7020
Open AccessAuto-inhibition of PRC2 by the broadly expressed long isoform of AEBP2
Polycomb Repressive Complex 2 (PRC2) is an essential chromatin regulator responsible for mono-, di- and tri-methylating H3K27. Control of PRC2 activity is a critical process in development and disease, yet no inhibitory cofactor has been identified in somatic cells. Here, we show that the alternative isoforms of its accessory subunit AEBP2, namely AEBP2 S (short) and AEBP2 L (long), perform opposite functions in modulating PRC2 activity. Contrary to prior assumptions that AEBP2 enhances PRC2 function, we find that the widely expressed AEBP2 L isoform inhibits it. AEBP2 L is expressed throughout embryogenesis and adulthood and inhibits PRC2 DNA binding, histone methyltransferase activity, and binding to target genes. In contrast, AEBP2 S , expressed during early embryogenesis, promotes PRC2 DNA-binding activity and is essential for de novo repression of target genes during the transition from naĂ¯ve to primed pluripotency. Mechanistically, through high-resolution cryo-EM and mutagenesis, we show that the recently evolved, negatively charged N-terminal region of AEBP2 L inhibits PRC2. We propose a scenario in which the N-terminus of AEBP2 L arose in vertebrates to restrain PRC2 activity in somatic cells.
- Open Access
- 15 January 2025
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 32  (3) , 520-530
Dynamic PRC1–CBX8 stabilizes a porous structure of chromatin condensates
The compaction of chromatin is a prevalent paradigm in gene repression. Chromatin compaction is commonly thought to repress transcription by restricting chromatin accessibility. However, the spatial organization and dynamics of chromatin compacted by gene-repressing factors are unknown. Here, using cryo-electron tomography, we solved the three-dimensional structure of chromatin condensed by the polycomb repressive complex 1 (PRC1) in a complex with CBX8. PRC1-condensed chromatin is porous and stabilized through multivalent dynamic interactions of PRC1 with chromatin. Mechanistically, positively charged residues on the internally disordered regions of CBX8 mask negative charges on the DNA to stabilize the condensed state of chromatin. Within condensates, PRC1 remains dynamic while maintaining a static chromatin structure. In differentiated mouse embryonic stem cells, CBX8-bound chromatin remains accessible. These findings challenge the idea of rigidly compacted polycomb domains and instead provide a mechanistic framework for dynamic and accessible PRC1–chromatin condensates.
- 15 January 2025
- Published by Springer Nature in Nature Structural & Molecular Biology
- Vol. 32  (3) , 520-530
Open AccessDynamic PRC1–CBX8 stabilizes a porous structure of chromatin condensates
The compaction of chromatin is a prevalent paradigm in gene repression. Chromatin compaction is commonly thought to repress transcription by restricting chromatin accessibility. However, the spatial organization and dynamics of chromatin compacted by gene-repressing factors are unknown. Here, using cryo-electron tomography, we solved the three-dimensional structure of chromatin condensed by the polycomb repressive complex 1 (PRC1) in a complex with CBX8. PRC1-condensed chromatin is porous and stabilized through multivalent dynamic interactions of PRC1 with chromatin. Mechanistically, positively charged residues on the internally disordered regions of CBX8 mask negative charges on the DNA to stabilize the condensed state of chromatin. Within condensates, PRC1 remains dynamic while maintaining a static chromatin structure. In differentiated mouse embryonic stem cells, CBX8-bound chromatin remains accessible. These findings challenge the idea of rigidly compacted polycomb domains and instead provide a mechanistic framework for dynamic and accessible PRC1–chromatin condensates.
- 14 January 2025
- Published by Springer Nature in Nature Chemical Biology
- Vol. 21  (6) , 959-970
Catalytic-independent functions of the Integrator–PP2A complex (INTAC) confer sensitivity to BET inhibition
Chromatin and transcription regulators are critical to defining cell identity through shaping epigenetic and transcriptional landscapes, with their misregulation being closely linked to oncogenesis. Pharmacologically targeting these regulators, particularly the transcription-activating BET proteins, has emerged as a promising approach in cancer therapy, yet intrinsic or acquired resistance frequently occurs, with poorly understood mechanisms. Here, using genome-wide CRISPR screens, we find that BET inhibitor efficacy in mediating transcriptional silencing and growth inhibition depends on the auxiliary/arm/tail module of the Integrator–PP2A complex (INTAC), a global regulator of RNA polymerase II pause–release dynamics. This process bypasses a requirement for the catalytic activities of INTAC and instead leverages direct engagement of the auxiliary module with the RACK7/ZMYND8–KDM5C complex to remove histone H3K4 methylation. Targeted degradation of the COMPASS subunit WDR5 to attenuate H3K4 methylation restores sensitivity to BET inhibitors, highlighting how simultaneously targeting coordinated chromatin and transcription regulators can circumvent drug-resistant tumors.
- 14 January 2025
- Published by Springer Nature in Nature Chemical Biology
- Vol. 21  (6) , 959-970
Catalytic-independent functions of the Integrator–PP2A complex (INTAC) confer sensitivity to BET inhibition
Chromatin and transcription regulators are critical to defining cell identity through shaping epigenetic and transcriptional landscapes, with their misregulation being closely linked to oncogenesis. Pharmacologically targeting these regulators, particularly the transcription-activating BET proteins, has emerged as a promising approach in cancer therapy, yet intrinsic or acquired resistance frequently occurs, with poorly understood mechanisms. Here, using genome-wide CRISPR screens, we find that BET inhibitor efficacy in mediating transcriptional silencing and growth inhibition depends on the auxiliary/arm/tail module of the Integrator–PP2A complex (INTAC), a global regulator of RNA polymerase II pause–release dynamics. This process bypasses a requirement for the catalytic activities of INTAC and instead leverages direct engagement of the auxiliary module with the RACK7/ZMYND8–KDM5C complex to remove histone H3K4 methylation. Targeted degradation of the COMPASS subunit WDR5 to attenuate H3K4 methylation restores sensitivity to BET inhibitors, highlighting how simultaneously targeting coordinated chromatin and transcription regulators can circumvent drug-resistant tumors.
- Open Access
- 14 May 2024
- Published by Springer Nature in Nature Genetics
- Vol. 56  (6) , 1193-1202
Inseparable RNA binding and chromatin modification activities of a nucleosome-interacting surface in EZH2
Polycomb repressive complex 2 (PRC2) interacts with RNA in cells, but there is no consensus on how RNA regulates PRC2 canonical functions, including chromatin modification and the maintenance of transcription programs in lineage-committed cells. We assayed two separation-of-function mutants of the PRC2 catalytic subunit EZH2, defective in RNA binding but functional in methyltransferase activity. We find that part of the RNA-binding surface of EZH2 is required for chromatin modification, yet this activity is independent of RNA. Mechanistically, the RNA-binding surface within EZH2 is required for chromatin modification in vitro and in cells, through interactions with nucleosomal DNA. Contrarily, an RNA-binding-defective mutant exhibited normal chromatin modification activity in vitro and in lineage-committed cells, accompanied by normal gene repression activity. Collectively, we show that part of the RNA-binding surface of EZH2, rather than the RNA-binding activity per se, is required for the histone methylation in vitro and in cells, through interactions with the substrate nucleosome.
- 14 May 2024
- Published by Springer Nature in Nature Genetics
- Vol. 56  (6) , 1193-1202
Open AccessInseparable RNA binding and chromatin modification activities of a nucleosome-interacting surface in EZH2
Polycomb repressive complex 2 (PRC2) interacts with RNA in cells, but there is no consensus on how RNA regulates PRC2 canonical functions, including chromatin modification and the maintenance of transcription programs in lineage-committed cells. We assayed two separation-of-function mutants of the PRC2 catalytic subunit EZH2, defective in RNA binding but functional in methyltransferase activity. We find that part of the RNA-binding surface of EZH2 is required for chromatin modification, yet this activity is independent of RNA. Mechanistically, the RNA-binding surface within EZH2 is required for chromatin modification in vitro and in cells, through interactions with nucleosomal DNA. Contrarily, an RNA-binding-defective mutant exhibited normal chromatin modification activity in vitro and in lineage-committed cells, accompanied by normal gene repression activity. Collectively, we show that part of the RNA-binding surface of EZH2, rather than the RNA-binding activity per se, is required for the histone methylation in vitro and in cells, through interactions with the substrate nucleosome.
- Open Access
- 15 November 2022
- Published by American Society of Hematology in Blood
- Vol. 140  (Supplement) , 9767-9768
EZH2 Inhibition Mediates Proptosis Via DHX9 and S100A9 in Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS) is considered as an archetypal epigenetic disorder due to the aberrant epigenome, frequent epigenetic regulator mutations and th
- 15 November 2022
- Published by American Society of Hematology in Blood
- Vol. 140  (Supplement) , 9767-9768
Open AccessEZH2 Inhibition Mediates Proptosis Via DHX9 and S100A9 in Myelodysplastic Syndromes
Myelodysplastic Syndromes (MDS) is considered as an archetypal epigenetic disorder due to the aberrant epigenome, frequent epigenetic regulator mutations and th
- Open Access
- 4 October 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 932034
Genome-wide association analysis of milk production, somatic cell score, and body conformation traits in Holstein cows
Milk production and body conformation traits are critical economic traits for dairy cows. To understand the basic genetic structure for those traits, a genome wide association study was performed on milk yield, milk fat yield, milk fat percentage, milk protein yield, milk protein percentage, somatic cell score, body form composite index, daily capacity composite index, feed, and leg conformation traits, based on the Illumina Bovine HD100k BeadChip. A total of 57, 12 and 26 SNPs were found to be related to the milk production, somatic cell score and body conformation traits in the Holstein cattle. Genes with pleiotropic effect were also found in this study. Seven significant SNPs were associated with multi-traits and were located on the PLEC, PLEKHA5, TONSL, PTGER4, and LCORL genes. In addition, some important candidate genes, like GPAT3, CEBPB, AGO2, SLC37A1, and FNDC3B, were found to participate in fat metabolism or mammary gland development. These results can be used as candidate genes for milk production, somatic cell score, and body conformation traits of Holstein cows, and are helpful for further gene function analysis to improve milk production and quality.
- 4 October 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 932034
Open AccessGenome-wide association analysis of milk production, somatic cell score, and body conformation traits in Holstein cows
Milk production and body conformation traits are critical economic traits for dairy cows. To understand the basic genetic structure for those traits, a genome wide association study was performed on milk yield, milk fat yield, milk fat percentage, milk protein yield, milk protein percentage, somatic cell score, body form composite index, daily capacity composite index, feed, and leg conformation traits, based on the Illumina Bovine HD100k BeadChip. A total of 57, 12 and 26 SNPs were found to be related to the milk production, somatic cell score and body conformation traits in the Holstein cattle. Genes with pleiotropic effect were also found in this study. Seven significant SNPs were associated with multi-traits and were located on the PLEC, PLEKHA5, TONSL, PTGER4, and LCORL genes. In addition, some important candidate genes, like GPAT3, CEBPB, AGO2, SLC37A1, and FNDC3B, were found to participate in fat metabolism or mammary gland development. These results can be used as candidate genes for milk production, somatic cell score, and body conformation traits of Holstein cows, and are helpful for further gene function analysis to improve milk production and quality.
- Open Access
- 21 August 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297  (4) , 101107
Structural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1
- 21 August 2021
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 297  (4) , 101107
Open AccessStructural and functional characterization of ubiquitin variant inhibitors for the JAMM-family deubiquitinases STAMBP and STAMBPL1
- Open Access
- 26 March 2021
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 49  (2) , 591-607
Allosteric regulation of histone lysine methyltransferases: from context-specific regulation to selective drugs
Histone lysine methyltransferases (HKMTs) are key regulators of many cellular processes. By definition, HKMTs catalyse the methylation of lysine residues in histone proteins. The enzymatic activities of HKMTs are under precise control, with their allosteric regulation emerging as a prevalent paradigm. We review the molecular mechanisms of allosteric regulation of HKMTs using well-studied histone H3 (K4, K9, K27 and K36) methyltransferases as examples. We discuss the current advances and future potential in targeting allosteric sites of HKMTs for drug development.
- 26 March 2021
- Published by Portland Press Ltd. in Biochemical Society Transactions
- Vol. 49  (2) , 591-607
Open AccessAllosteric regulation of histone lysine methyltransferases: from context-specific regulation to selective drugs
Histone lysine methyltransferases (HKMTs) are key regulators of many cellular processes. By definition, HKMTs catalyse the methylation of lysine residues in histone proteins. The enzymatic activities of HKMTs are under precise control, with their allosteric regulation emerging as a prevalent paradigm. We review the molecular mechanisms of allosteric regulation of HKMTs using well-studied histone H3 (K4, K9, K27 and K36) methyltransferases as examples. We discuss the current advances and future potential in targeting allosteric sites of HKMTs for drug development.
- 1 October 2019
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 164, 107063
Elaborately rehearsed information can be forgotten: A new paradigm to investigate directed forgetting
- 1 October 2019
- Published by Elsevier in Neurobiology of Learning and Memory
- Vol. 164, 107063
Elaborately rehearsed information can be forgotten: A new paradigm to investigate directed forgetting
- Open Access
- 1 June 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294  (25) , 9844-9857
USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis
- 1 June 2019
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 294  (25) , 9844-9857
Open AccessUSP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis